Market Insights NEWS

Healthcare dealmaking has picked up sharply through the first half of 2026, even as reimbursement pressure, tariff uncertainty, and drug pricing policy continue to create headline risk. Recent midyear outlooks point to a sector that is not pulling back on M&A, but instead getting more selective about where it deploys capital. Biopharma Leads the Charge Biopharma has posted its strongest dealmaking quarter in years, with deal value in the first quarter alone exceeding sixty fi

Artificial intelligence is no longer an experimental add-on in healthcare, it is quickly becoming core infrastructure. From diagnostic imaging to hospital operations, AI-driven tools are reshaping how care is delivered, priced, and scaled. Here is what is driving the market in 2026, and where the opportunities lie for investors, health systems, and technology vendors. Why the AI Healthcare Market Is Accelerating Three forces are converging to push adoption faster than earlier

The Future of Healthcare: Trends, Challenges, and Opportunities Executive Summary The healthcare industry is undergoing a significant...

LabGenomics USA, a subsidiary of South Korea’s LabGenomics, has been strategically expanding its footprint in the U.S. diagnostics...

Fabric, a leader in healthcare technology, has announced its acquisition of TeamHealth VirtualCare, a nationwide virtual care provider...